ArticleInternational ophthalmology2025
Visual outcomes of aberration neutral versus monofocal plus IOLs in triple DMEK surgery.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo compare visual acuity outcomes of two monofocal IOL models, a zero-aberration monofocal IOL (Envista MX60E; Bausch and Lomb) and a monofocal plus IOL (Eyhance DIB00; Johnson and Johnson), in eyes undergoing combined cataract surgery and Descemet membrane endothelial keratoplasty (DMEK) (triple DMEK).
methodsRetrospective, single-center case series of 91 eyes (66 patients) undergoing triple DMEK with either IOL between 2019 and 2023 at a tertiary academic center. Eyes were divided into 2 groups: zero-aberration IOL (49 eyes) and monofocal plus IOL (42 eyes). Among these, 20 eyes received a zero-aberration IOL, and 26 eyes received a monofocal plus IOL in both eyes. Visual acuity measurements at 3-6 months and 6-12 months postoperatively included uncorrected distance, intermediate, and near (UDVA, UIVA, UNVA) and distance-corrected distance, intermediate, and near (CDVA, DCIVA, DCNVA) visual acuities for monocular (Uni) and binocular (Bi) assessments. Patients were administered the Intraocular Lens Satisfaction questionnaire to assess their level of spectacle independence at the 3-6 month visit. Statistical analysis was performed using Wilcoxon rank-sum and Fisher's exact tests.
resultsUDVA
conclusionBoth IOLs can provide favorable corrected and uncorrected VA in triple DMEK eyes. Eyhance may provide better DCIVA
Indexed as
Identifiers
40381067What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.